JP2024539080A5 - - Google Patents
Info
- Publication number
- JP2024539080A5 JP2024539080A5 JP2024523274A JP2024523274A JP2024539080A5 JP 2024539080 A5 JP2024539080 A5 JP 2024539080A5 JP 2024523274 A JP2024523274 A JP 2024523274A JP 2024523274 A JP2024523274 A JP 2024523274A JP 2024539080 A5 JP2024539080 A5 JP 2024539080A5
- Authority
- JP
- Japan
- Prior art keywords
- expression
- progenitor cells
- pharmaceutical product
- glial progenitor
- product according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163257827P | 2021-10-20 | 2021-10-20 | |
| US63/257,827 | 2021-10-20 | ||
| US202263350041P | 2022-06-08 | 2022-06-08 | |
| US202263350039P | 2022-06-08 | 2022-06-08 | |
| US202263350042P | 2022-06-08 | 2022-06-08 | |
| US63/350,039 | 2022-06-08 | ||
| US63/350,041 | 2022-06-08 | ||
| US63/350,042 | 2022-06-08 | ||
| PCT/US2022/047083 WO2023069482A1 (en) | 2021-10-20 | 2022-10-19 | Compositions and methods for treating myelin deficiency by rejuvenating glial progenitor cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024539080A JP2024539080A (ja) | 2024-10-28 |
| JP2024539080A5 true JP2024539080A5 (https=) | 2025-10-14 |
Family
ID=84359179
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024523274A Pending JP2024539080A (ja) | 2021-10-20 | 2022-10-19 | グリア前駆細胞を若返らせることによってミエリン欠乏症を処置するための組成物及び方法 |
| JP2024523275A Pending JP2024539081A (ja) | 2021-10-20 | 2022-10-19 | 転写因子の抑圧によってｃｎｓグリア集団を若返らせるための方法及び組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024523275A Pending JP2024539081A (ja) | 2021-10-20 | 2022-10-19 | 転写因子の抑圧によってｃｎｓグリア集団を若返らせるための方法及び組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (4) | US12565648B2 (https=) |
| EP (2) | EP4419685A1 (https=) |
| JP (2) | JP2024539080A (https=) |
| AU (2) | AU2022370552A1 (https=) |
| CA (3) | CA3235458A1 (https=) |
| WO (3) | WO2023069478A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023069478A1 (en) * | 2021-10-20 | 2023-04-27 | University Of Rochester | Methods and compositions for rejuvenating cns glial populations by suppression of transcription factors |
| EP4604985A1 (en) * | 2022-10-19 | 2025-08-27 | University of Rochester | Methods and compositions for rejuvenating cns glial populations with bcl11a transcription factor expression |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US748529A (en) | 1903-09-03 | 1903-12-29 | Troy Laundry Machinery Co Ltd | Marking-machine. |
| US5872005A (en) | 1994-11-03 | 1999-02-16 | Cell Genesys Inc. | Packaging cell lines for adeno-associated viral vectors |
| GB9710809D0 (en) | 1997-05-23 | 1997-07-23 | Medical Res Council | Nucleic acid binding proteins |
| ES2341926T3 (es) | 1998-03-02 | 2010-06-29 | Massachusetts Institute Of Technology | Poliproteinas con dedos de cinc que tienen enlazadores mejorados. |
| US7013219B2 (en) | 1999-01-12 | 2006-03-14 | Sangamo Biosciences, Inc. | Regulation of endogenous gene expression in cells using zinc finger proteins |
| US6534261B1 (en) | 1999-01-12 | 2003-03-18 | Sangamo Biosciences, Inc. | Regulation of endogenous gene expression in cells using zinc finger proteins |
| US6794136B1 (en) | 2000-11-20 | 2004-09-21 | Sangamo Biosciences, Inc. | Iterative optimization in the design of binding proteins |
| US20030104526A1 (en) | 1999-03-24 | 2003-06-05 | Qiang Liu | Position dependent recognition of GNN nucleotide triplets by zinc fingers |
| US7030215B2 (en) | 1999-03-24 | 2006-04-18 | Sangamo Biosciences, Inc. | Position dependent recognition of GNN nucleotide triplets by zinc fingers |
| WO2002088346A2 (en) | 2001-05-01 | 2002-11-07 | National Research Council Of Canada | A system for inducible expression in eukaryotic cells |
| WO2003070171A2 (en) | 2002-02-15 | 2003-08-28 | Cornell Research Foundation, Inc. | Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells |
| US20040029269A1 (en) | 2002-05-07 | 2004-02-12 | Goldman Steven A | Promoter-based isolation, purification, expansion, and transplantation of neuronal progenitor cells, oligodendrocyte progenitor cells, or neural stem cells from a population of embryonic stem cells |
| US7485291B2 (en) | 2003-06-03 | 2009-02-03 | Cell Genesys, Inc. | Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereof |
| US8728759B2 (en) | 2004-10-04 | 2014-05-20 | National Research Council Of Canada | Reverse cumate repressor mutant |
| WO2011072246A2 (en) | 2009-12-10 | 2011-06-16 | Regents Of The University Of Minnesota | Tal effector-mediated dna modification |
| EP2951588A4 (en) * | 2013-01-30 | 2016-11-16 | Benaroya Res Inst At Virginia Mason | EFFeCtor T-CELL RESISTANCE |
| HUE053191T2 (hu) | 2017-02-09 | 2021-06-28 | Bayer Ag | 2-Heteroaril-3-oxo-2,3-dihidropiridazin-4-karboxamidok rák kezelésére |
| US12365872B2 (en) * | 2018-09-19 | 2025-07-22 | Lineage Cell Therapeutics, Inc. | Methods for differentiating pluripotent stem cells in dynamic suspension culture |
| US20230057355A1 (en) | 2019-02-13 | 2023-02-23 | University Of Rochester | Gene networks that mediate remyelination of the human brain |
| CA3167135A1 (en) | 2020-02-06 | 2021-08-12 | Emerald Health Pharmaceuticals Inc. | Composition and method for the treatment and prevention of cardiac, pulmonary, dermal, and renal fibrosis |
| GB2625500B (en) | 2021-09-21 | 2026-04-01 | Scribe Therapeutics Inc | Engineered CasX repressor systems |
| WO2023069478A1 (en) | 2021-10-20 | 2023-04-27 | University Of Rochester | Methods and compositions for rejuvenating cns glial populations by suppression of transcription factors |
| CA3234809A1 (en) | 2021-10-20 | 2023-04-27 | Steven Goldman | Isolated glial progenitor cells for use in the competition treatment of age-related white matter loss |
-
2022
- 2022-10-19 WO PCT/US2022/047079 patent/WO2023069478A1/en not_active Ceased
- 2022-10-19 JP JP2024523274A patent/JP2024539080A/ja active Pending
- 2022-10-19 WO PCT/US2022/047085 patent/WO2023069484A1/en not_active Ceased
- 2022-10-19 US US17/968,984 patent/US12565648B2/en active Active
- 2022-10-19 US US18/047,744 patent/US20230190961A1/en active Pending
- 2022-10-19 EP EP22823646.9A patent/EP4419685A1/en active Pending
- 2022-10-19 JP JP2024523275A patent/JP2024539081A/ja active Pending
- 2022-10-19 EP EP22803427.8A patent/EP4419679A1/en active Pending
- 2022-10-19 WO PCT/US2022/047083 patent/WO2023069482A1/en not_active Ceased
- 2022-10-19 US US18/047,749 patent/US20230133695A1/en active Pending
- 2022-10-19 CA CA3235458A patent/CA3235458A1/en active Pending
- 2022-10-19 AU AU2022370552A patent/AU2022370552A1/en active Pending
- 2022-10-19 CA CA3235250A patent/CA3235250A1/en active Pending
- 2022-10-19 AU AU2022369984A patent/AU2022369984A1/en active Pending
- 2022-10-19 CA CA3234634A patent/CA3234634A1/en active Pending
-
2023
- 2023-09-14 US US18/467,442 patent/US20240167034A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ginn et al. | Gene therapy clinical trials worldwide to 2023—an update | |
| Sparmann et al. | RNA‐based medicine: from molecular mechanisms to therapy | |
| Matharu et al. | Modulating gene regulation to treat genetic disorders | |
| JP2024539080A5 (https=) | ||
| JP7591847B2 (ja) | デュシェンヌ型筋ジストロフィーに関連するエクソンスプライシングエンハンサー、ｓｇＲＮＡ、遺伝子編集ツールおよび使用 | |
| JP2023529315A (ja) | 機能的ａａｖカプシドのハイスループット工学操作 | |
| JP2021502060A5 (https=) | ||
| Azzouz | Gene Therapy for ALS: progress and prospects | |
| CN113164624B (zh) | 恢复人类快乐木偶综合征中父系ube3a基因表达的组合物和方法 | |
| US20160108402A1 (en) | Methods for diagnosing and treating learning or mental disorders | |
| JP2025513066A5 (https=) | ||
| CA3120534A1 (en) | Oligomeric nucleic acid molecule and use thereof | |
| JP2024539081A5 (https=) | ||
| JP2023506842A5 (https=) | ||
| US20240238447A1 (en) | Compositions and methods for modulating payload expression at a transcriptional level | |
| KR101779775B1 (ko) | 간세포 성장인자의 둘 이상의 이형체를 이용한 근위축성 측삭 경화증 예방 또는 치료용 조성물 | |
| Wu et al. | The Impact of Splicing Dysregulation on Neuromuscular Disorders and Current Neuromuscular Genetic Therapies | |
| US20220081690A1 (en) | Use of mir-204 inhibitor to increase nurr1 protein expression | |
| JP2023525476A5 (https=) | ||
| JP2024542015A5 (https=) | ||
| CN115702246A (zh) | 调节性核酸序列 | |
| Palacios-Reyes et al. | Williams' neural stem cells: new model for insight into microRNA dysregulation | |
| US10426846B2 (en) | OLIG1 mini-promoters: PIe305 | |
| US20230121720A1 (en) | Diagnostic methods using pcg-1a expression | |
| US20220106614A1 (en) | Dlx2 vector |